Serlopitant, a potent and highly specific NK1 receptor antagonist, is an investigational drug that acts through a novel mechanism to interrupt pruritus (itch) and potentially cough. Serlopitant may be a first in class once-daily oral tablet therapy for relief of itch or cough.